Unexpected suppression of tumorigenesis by c-MYC via TFAP4-dependent restriction of stemness in B lymphocytes
Open Access
- 16 December 2021
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 138 (24) , 2526-2538
Abstract
The proliferative burst of B lymphocytes is essential for antigen receptor repertoire diversification during the development and selective expansion of antigen-specific clones during immune responses. High proliferative activity inevitably promotes oncogenesis, the risk of which is further elevated in B lymphocytes by endogenous gene rearrangement and somatic mutations. However, B-cell–derived cancers are rare, perhaps owing to putative intrinsic tumor-suppressive mechanisms. We show that c-MYC facilitates B-cell proliferation as a protumorigenic driver and unexpectedly coengages counteracting tumor suppression through its downstream factor TFAP4. TFAP4 is mutated in human lymphoid malignancies, particularly in >10% of Burkitt lymphomas, and reduced TFAP4 expression was associated with poor survival of patients with MYC-high B-cell acute lymphoblastic leukemia. In mice, insufficient TFAP4 expression accelerated c-MYC–driven transformation of B cells. Mechanistically, c-MYC suppresses the stemness of developing B cells by inducing TFAP4 and restricting self-renewal of proliferating B cells. Thus, the pursuant transcription factor cascade functions as a tumor suppressor module that safeguards against the transformation of developing B cells.Keywords
This publication has 66 references indexed in Scilit:
- The Transcription Factor Myc Controls Metabolic Reprogramming upon T Lymphocyte ActivationImmunity, 2011
- Hematopoietic stem cell: self‐renewal versus differentiationWIREs Mechanisms of Disease, 2010
- PI3 Kinase Signals BCR-Dependent Mature B Cell SurvivalCell, 2009
- AP4 encodes a c-MYC-inducible repressor of p21Proceedings of the National Academy of Sciences, 2008
- Activation-induced cytidine deaminase (AID) promotes B cell lymphomagenesis in Emu-cmyc transgenic miceProceedings of the National Academy of Sciences, 2007
- Testing gene function early in the B cell lineage in mb1-cre miceProceedings of the National Academy of Sciences, 2006
- Tracking germinal center B cells expressing germ-line immunoglobulin γ1 transcripts by conditional gene targetingProceedings of the National Academy of Sciences, 2006
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences, 2005
- Evasion of the p53 tumour surveillance network by tumour-derived MYC mutantsNature, 2005
- The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic miceNature, 1985